Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
AbbVie Inc | 296.5B | 59.9x | -6.05% |
Amgen Inc | 154.7B | 37.1x | -0.22% |
AstraZeneca PLC | 196.0B | 30.9x | +17.52% |
Eli Lilly and Co | 715.2B | 81.0x | +12.51% |
Gilead Sciences Inc | 110.5B | 1,068.7x | +1.53% |
Jazz Pharmaceuticals PLC | 7.2B | 17.6x | -3.53% |
Johnson & Johnson | 368.6B | 25.6x | -1.47% |
Kali Inc | 1.0K | 0.0x | --- |
Merck & Co Inc | 246.5B | 20.9x | -43.23% |
Novartis AG | 225.9B | 18.1x | -5.59% |
Organon & Co | 3.8B | 3.0x | -14.04% |
Pfizer Inc | 141.3B | 33.8x | -7.10% |
Sanofi SA | 122.1B | 25.3x | +4.55% |
Altamira Therapeutics Ltd | 1.7M | 0.6x | --- |
Amphastar Pharmaceuticals Inc | 2.1B | 14.8x | --- |
Bavarian Nordic A/S | 2.2B | 13.2x | --- |
Biostem Technologies Inc | 196.0M | 21.4x | --- |
Bon Natural Life Ltd | 5.8M | 0.6x | +78.05% |
Collegium Pharmaceutical Inc | 967.5M | 15.2x | --- |
Corcept Therapeutics Inc | 5.9B | 44.1x | +9.80% |
Daiichi Sankyo Co Ltd | 56.7B | 34.5x | --- |
Dr Reddy's Laboratories Ltd | 12.0B | 18.5x | +24.18% |
Earth Science Tech Inc | 48.6M | 17.3x | --- |
Endexx Corp | --- | 0.8x | --- |
GSK plc | 68.3B | 21.9x | +6.39% |
Haleon PLC | 42.3B | 17.9x | --- |
Harmony Biosciences Holdings Inc | 1.9B | 15.7x | --- |
Innoviva Inc | 1.2B | 27.7x | -8.76% |
Integrated Biopharma Inc | 10.2M | 24.9x | -42.26% |
Invitro International | 1.8M | 228.6x | -17.03% |
Lifecore Biomedical Inc | 275.5M | 189.0x | +27.97% |
LifeVantage Corp | 162.0M | 41.2x | -14.53% |
Ligand Pharmaceuticals Inc | 2.1B | 48.0x | -12.71% |
Novo Nordisk A/S | 355.5B | 34.2x | +18.50% |
Prestige Consumer Healthcare Inc | 4.1B | 20.5x | --- |
Procaps Group SA | 64.5M | 2.1x | --- |
Puma Biotechnology Inc | 139.4M | 6.1x | --- |
Rigel Pharmaceuticals Inc | 428.2M | 115.9x | --- |
Roche Holding AG | 230.4B | 18.9x | +3.28% |
Roivant Sciences Ltd | 8.4B | 2.1x | --- |
Royalty Pharma PLC | 15.4B | 10.3x | +1.83% |
SIGA Technologies Inc | 446.1M | 5.3x | -28.78% |
Takeda Pharmaceutical Co Ltd | 43.0B | 22.8x | -8.01% |
United-Guardian Inc | 44.6M | 13.0x | -9.92% |
60 Degrees Pharmaceuticals Inc | 1.7M | -0.1x | --- |
AgriFORCE Growing Systems Ltd | 5.0M | 0.0x | --- |
Akanda Corp | --- | 0.0x | --- |
Akari Therapeutics PLC | 36.4M | -0.4x | --- |
Alnylam Pharmaceuticals Inc | 32.1B | -94.2x | --- |
Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.
| Company | Dividend Yield |
|---|---|
Organon & Co | 7.60% |
Takeda Pharmaceutical Co Ltd (ADR) | 7.21% |
Pfizer Inc | 6.74% |
United-Guardian, Inc. | 6.18% |
GSK plc (ADR) | 4.71% |